Gemzar

DRUG8 trials

Conditions

Advanced Pancreatic AdenocarcinomaBladder CancerMetastases, NeoplasmMetastatic Pancreatic CancerMuscle-Invasive Bladder CarcinomaNon Small Cell Lung CancerPancreatic AdenocarcinomaPancreatic Cancer

Early Phase 1

Bladder Preservation or Cystectomy for MIBC

Active, not recruitingNCT07821177

Dana-Farber Cancer InstituteBladder Cancer, Muscle-Invasive Bladder Carcinoma, Urothelial Carcinoma

Start: 2026-09-02End: 2029-09-01Target: 20Updated: 2026-09-15

Phase 1

Lenalidomide and Gemcitabine as First-line Treatment in Patients With Pancreatic Cancer

CompletedNCT01547260

Maria LiljeforsPancreatic Carcinoma Metastatic, Pancreatic Ductal Adenocarcinoma

Start: 2009-10-31End: 2014-11-30Updated: 2022-08-22

Ultrasound-assisted Treatment of Inoperable Pancreatic Cancer

CompletedNCT01674556

Haukeland University HospitalPancreatic Adenocarcinoma

Start: 2012-02-29End: 2015-01-31Updated: 2015-09-24

Afatinib and Gemcitabine/Nab-paclitaxel in Metastatic Pancreatic Cancer

NCT02975141

PD Dr. med. Volker HeinemannMetastatic Pancreatic Cancer

Start: 2016-09-30End: 2019-06-30Updated: 2018-08-13

A Clinical Study of AL2846 Capsule Combined With Gemzar Injection in the Treatment of Advanced Pancreatic Cancer

CompletedNCT06278493

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Pancreatic Cancer

Start: 2018-08-23End: 2023-05-01Updated: 2024-02-26

Phase 2

ZN-c3 + Gemcitabine in Pancreatic Cancer

TerminatedNCT06015659

Brandon Huffman, MDAdvanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma

Start: 2023-11-16End: 2026-05-23Updated: 2026-10-27

Phase 3

A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.

CompletedNCT00035035

Eli Lilly and CompanyMetastases, Neoplasm, Pancreatic Neoplasms

Updated: 2006-07-19

Unknown Phase

Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC)

CompletedNCT00419042

Groupe Francais De Pneumo-CancerologieNon Small Cell Lung Cancer

Start: 2006-07-31End: 2010-03-31Updated: 2013-10-01

2025-01-06

A Phase II Trial of the WEE1 Inhibitor Adavosertib in <i>SETD2</i> <i>-</i> Altered Advanced Solid Tumor Malignancies (NCI 10170)

Cancer Research Communications2024-06-2611 citations

Targeting replication stress in pancreatic cancer: A phase II trial investigating azenosertib in combination with gemcitabine in second-line advanced pancreatic cancer.

Journal of Clinical Oncology2024-06-01

Clinical and Immune Effects of Lenalidomide in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer

PLoS ONE2017-01-1817 citations

Ultrasound and microbubble enhanced treatment of inoperable pancreatic adeonocarcinoma.

Journal of Clinical Oncology2016-05-203 citations

A Phase I Dose-Escalation Study of Lenalidomide in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer

PLoS ONE2015-04-028 citations